The GSK India product portfolio includes prescription medicines and vaccines. Our prescription medicines range across therapeutic areas and we also offer a range of vaccines for prevention of life-threatening diseases.
We are committed to Research and Development of medicines that will improve the quality of life of people around the world and truly make a difference to patients. In 2015, at GSK India, we conducted clinical studies in infectious diseases, oncology, and respiratory diseases. We have submitted several applications for New Products in India to the CDSCO (Central Drugs Standard Control Organization), Ministry of Health and Family Welfare, Government of India. All new products and indications approved for the company will be beneficial to Indian patients.
We produce medicines for the treatment of major disease areas such as asthma, infectious diseases, mental health and digestive conditions.
We are a leader in the important area of vaccines and are developing new treatments for cancer. In 2015 we acquired Novartis’ global Vaccines business (excluding influenza vaccines).
We have a heritage that goes back more than 160 years, producing some of the world’s best-loved healthcare brands. In India, GSK has separate listed companies for its pharmaceutical and consumer businesses. To visit our consumer business website, please follow the link www.gsk-ch.in